| 10494433 |
Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma |
Pascale Andre, Mathieu Blery, Cecile Bonnafous, Luisa Salter-Cid, Michael Robbins |
2019-12-03 |
| 10323092 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
| 10323093 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-18 |
| 10316090 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
| 10316091 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-11 |
| 10308714 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-06-04 |
| 10266595 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
| 10266596 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |
| 10266594 |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
John P. Cogswell, Stacie M. Goldberg, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton |
2019-04-23 |